ReviewThe Indian journal of medical research2025
Multi-sensor wearables re-shaping care of chronic heart-failure: A narrative review.
Review in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-sensor wearables for chronic heart failure: From signal-rich devices to equitable, implementable pathways.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart-failure decompensation often evolves between visits, driving recurrent admissions and cost. Multi-sensor wearables, adhesive patches, smart watches, and garments capture electrocardiography, thoracic impedance, photoplethysmography, respiration, activity, and speech for near-real-time review. Evidence synthesis indicates two signals. First, integrated telemonitoring, combined with structured clinical intervention during the post-discharge vulnerable phase, reduces cardiovascular events and heart failure hospitalisations in randomised programmes. Second, device-level performance metrics (lead time, alert burden, detection accuracy) demonstrate early warning capability but do not alone establish outcome benefit. Implantable multi-sensor algorithms offer a median lead time of approximately one month, accompanied by manageable alert rates. External systems that estimate lung fluid or fuse wearable signals demonstrate promising feasibility, although large pragmatic trials remain limited. Consumer smartwatches achieve high accuracy for detection of atrial fibrillation in general population; however, evidence is lacking for detection of heart failure decompensation, or for improving the outcome. Key implementation issues include AI-validation, workflow-linked triage, cost-effectiveness, cybersecurity, and equitable access for low- and middle-income settings. Multi-sensor monitoring warrants targeted deployment within intervention pathways and rigorous evaluation focused on patient-important outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.